Gene Sequencing and Pharma Companies - Clinical Research Informer

Takeda grows in gene therapies again with $2bn Code Bio deal

pharmaphorum

FEBRUARY 23, 2022

Interest in non-viral methods of delivering gene therapies has been growing in the face of current scrutiny of the safety of viral vectors like adeno-associated viruses (AAV), with a number of clinical programmes based on AAV under clinical holds imposed by the FDA.

Gene Therapy

Gene Therapy Gene Gene Sequencing Immune Response

Touchlight boosts DNA manufacturing capacity with latest expansion

Pharmaceutical Technology

MAY 26, 2023

The British company’s expanded facilities boasts of 11 suites, including two class B filling suites with class A filling cabinets, warehousing and quality control laboratory capability. One big pharma company has already given the seal of approval with a successful customer quality audit.

DNA

DNA Manufacturing Gene Gene Therapy

Clinical Research Informer

Takeda grows in gene therapies again with $2bn Code Bio deal

Touchlight boosts DNA manufacturing capacity with latest expansion

Webinars

Stay Connected